Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.10.2019 | Case report

Antineoplastics

Neutropenia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Yamao K, et al. Clinical safety and efficacy of secondary prophylactic pegylated G-CSF in advanced pancreatic cancer patients treated with mFOLFIRINOX: A single-center retrospective study. Internal Medicine 58: 1993-2002, No. 14, Jul 2019. Available from: URL: http://doi.org/10.2169/internalmedicine.2234-18 - Japan Yamao K, et al. Clinical safety and efficacy of secondary prophylactic pegylated G-CSF in advanced pancreatic cancer patients treated with mFOLFIRINOX: A single-center retrospective study. Internal Medicine 58: 1993-2002, No. 14, Jul 2019. Available from: URL: http://​doi.​org/​10.​2169/​internalmedicine​.​2234-18 - Japan
Metadaten
Titel
Antineoplastics
Neutropenia: case report
Publikationsdatum
01.10.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-68791-8

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Ibrutinib

Case report

Pyrimethamine

Case report

Ethiodized oil

Case report

Prasugrel

Case report

Osimertinib